ThreatsDay Bulletin: WhatsApp Hijacks, MCP Leaks, AI Recon, React2Shell Exploit and 15 More Stories
This week’s ThreatsDay Bulletin tracks how attackers keep reshaping old tools and finding new angles in familiar systems. Small changes in tactics are stacking up fast, and each one hints at where the next big breach could come from. From shifting infrastructures to clever social hooks, the week’s activity shows just how fluid the threat landscape has become. Here’s the...
HPE OneView Flaw Rated CVSS 10.0 Allows Unauthenticated Remote Code Execution
Hewlett Packard Enterprise (HPE) has resolved a maximum-severity security flaw in OneView Software that, if successfully exploited, could result in remote code execution. The critical vulnerability, assigned the CVE identifier CVE-2025-37164, carries a CVSS score of 10.0. HPE OneView is an IT infrastructure management software that streamlines IT operations and controls all...
Antibodies to watch in 2026
Thursday 29 January 2026 07:00 10:00 15:00 In this webinar, presented in association with the journal mAbs, Drs. Crescioli and Reichert discuss recent trends in antibody therapeutics development and forecast key events that may occur in 2026. They will begin with a brief review of approvals from 2025, the product candidates with marketing applications under consideration...
Key Signs of Mental Health Struggles in Security
John Rodriguez, Founder of Empathic Security Cultures LLC, shares why mental health is so crucial in security. Continue reading →
No More Failures of Imagination: Future Proofing Airport Employee Screening
How to protect American flyers and airport employees from another tragic “failure of imagination.” Continue reading →
630M Passwords Stolen, FBI Reveals: What This Says About Credential Value
630 million passwords were stolen, highlighting the value of passwords and password protection. Continue reading →
Peanut allergy patch succeeds in late-stage study 5 years after FDA rejection
DBV Technologies plans to use the latest Phase 3 results in a new submission to U.S. regulators in 2026. Continue reading →
FDA clears GSK’s twice-yearly asthma drug
Exdensur is now the first asthma biologic to be approved for twice-yearly dosing, and could potentially change standard of care for those with severe disease. Continue reading →
Orum, a biotech marrying ADCs with protein degraders, captures $100M in funding
The financing follows a strategic shift for Orum, which shelved its original lead program and is now pursuing a potential blood cancer treatment. Continue reading →
Bulgari Names Laura Burdese Chief Executive Officer
Burdese was previously deputy CEO and will take on the lead on July 1, succeeding Jean-Christophe Babin. Continue reading →
Jessie Buckley Pays Homage to Her ‘Hamnet’ Character in Red Carven Look
The Oscar-nominated actress stars in the film adaptation of Maggie O’Farrell’s novel. Continue reading →
